ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 3,440.00
+45.00 (1.33%)
At close: Aug 11, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 313.98 billion as of August 12, 2026. Its market cap has decreased by -16.37% in one year.
Market Cap
313.98B
Enterprise Value
295.04B
Revenue
59.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,440.00
ChartMarket Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 313.98B, a decrease of -42.66%. That is a compound annual growth rate of -36.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 313.98B | -67.48% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 700.70B |
| HEM Pharma | 302.12B |
| NOVAREX | 289.00B |
| Cosmax Nbt | 219.94B |
| DAE HWA Pharmaceutical | 199.69B |
| CellBion | 185.19B |
| Vivozon Pharmaceutical | 172.37B |
| GC WellBeing | 163.76B |